Aflac’s durable moat and aggressive buybacks support defensive compounding, but mature Japan and limited sales growth make AFL a valuation-sensitive hold.
Overview
Aflac is a specialized supplemental insurer with two profitable engines: Japan, which generates roughly 71% of pre-tax adjusted earnings, and the U.S. worksite voluntary-benefits business. Its direct cash-benefit model, iconic brand, payroll-deduction distribution, and high persistency create a defensive franchise with strong customer inertia. However, Japan is mature and shrinking, while yen depreciation has suppressed translated results; consolidated revenue declined from $21,554 million in FY 2021 to $17,164 million in FY 2025, implying a historical five-year sales CAGR of approximately -5.5%. Q2 2026 revenue fell 1.0% to $4,117 million and adjusted EPS declined 1.7% to $1.75, missing consensus, although GAAP EPS rose 46.8% to $1.63 as investment losses declined. **Capital returns remain the central support:** Aflac returned $1.3 billion in Q2 through $983 million of buybacks and $309 million of dividends. At $125.56, the shares trade at 14.38x trailing earnings and 2.18x book value. The principal catalysts are yen stabilization, U.S. broker-led group growth, operating efficiencies, and scaling Aflac Re. The five-year weighted target is $136.09, supporting a defensive hold or selective long-term purchase rather than a high-growth thesis.